The FDA authorization of direct-to-consumer genetic testing for three BRCA1/2 pathogenic variants: a twitter analysis of the public’s response

OBJECTIVES: In March 2018, the Food and Drug Administration (FDA) announced its authorization of a direct-to-consumer (DTC) genetic test for three pathogenic BRCA1/2 variants. We sought to determine to whether social media discussion increased following the authorization, who was driving social medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Megan C, Allen, Caitlin G, Andersen, Brittany L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993995/
https://www.ncbi.nlm.nih.gov/pubmed/32025636
http://dx.doi.org/10.1093/jamiaopen/ooz037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993995/
https://www.ncbi.nlm.nih.gov/pubmed/32025636
http://dx.doi.org/10.1093/jamiaopen/ooz037

Ejemplares similares